Does Adjuvant Systemic Therapy Improve Prognosis in Breast Cancer with 4-9 Axillary Nodes and in the Age Group of 80 Years or More?

Publisher： Karger

E-ISSN： 2296-5262|21|5|394-400

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.5, 1998-11, pp. : 394-400

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant systemic therapy for elderly women with breast cancer

By Henry N Lynn   Diehl Kathleen M   Hayes Daniel F  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 75-87

Future Medicine

Access to resources Recommend Favorite

Dose-Dense Adjuvant Chemotherapy with Epirubicin Monotherapy in Patients with Operable Breast Cancer and ≥10 Positive Axillary Lymph Nodes

By  

Oncology, Vol. 55, Iss. 6, 1998-10 ,pp. : 508-512

Karger

Access to resources Recommend Favorite

Adjuvant systemic therapy for older adults with early-stage breast cancer

By Pal Sumanta Kumar   Mortimer Joanne  

Women's Health, Vol. 5, Iss. 3, 2009-05 ,pp. : 251-262

Future Medicine

Access to resources Recommend Favorite

CT‐Guided Wire Localization for Involved Axillary Lymph Nodes After Neo‐adjuvant Chemotherapy in Patients With Initially Node‐Positive Breast Cancer

By  

THE BREAST JOURNAL, Vol. 22, Iss. 4, 2016-07 ,pp. : 390-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bisphosphonates as adjuvant therapy for breast cancer

By Burkinshaw Roger   Coleman Robert  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 115-126

Future Medicine

Access to resources Recommend Favorite